Activity value 93united states Buyer&Supplier,Last transaction date:
2026-02-18Address: 250 massachusetts avenue cambridge ma 02139 united states
Overview
Contact
Import data
Partners
HS Codes
Products
Areas
Ports
Trade trend analysis
Mon
|
Year
Number of TransactionsQuantityWeight
Number of TransactionsQuantityWeight
The above chart presents the market trend analysis for novartis institutes of biomedical from 2025 to 2026.
By examining various dimensions such as transaction quantity, transaction weight, average price,
and transaction frequency, we can gain an intuitive understanding of the company's performance in terms of procurement cycles, business scale, and stability.
As of 2026, the company has completed 41 transactions, with a transaction quantity of 96.57 and a transaction weight of 0.
YearTransactionsQuantityWeight
202534116.820
20264196.570
Bill of lading data
<
1/15
>
Trade date
2026/02/18
B/L No.
0403600
Suppliers
sapala organics pvt ltd.
Buyers
novartis institutes of biomedical
novartis institutes of biomedical is united states Buyer&Supplier,
and primarily engages in the import and export business of products such as riva,hetero,cycle.
According to the 52wmb.com global trade database, as of 2026-02-18, the company has completed 1298 international trades,
with its main trading regions covering india,belgium,france etc.
The core products include HS29349990,HS29335990,HS29339990 etc,
often transported via new york,port boston, port john f. kennedy apt/new york etc,
and its main trading partners are aurigene discovery technologies ltd.,sapala organics pvt ltd.,aurigene pharmaceutical services ltd..
These trade data are sourced from various countries' customs and public channels, and have undergone standardization and structuring processing.
They can reflect the import and export trends and main market layout of the enterprise, and are suitable for market trend analysis, competitor research, port transportation planning, supply chain optimization, and international customer development.
They provide reliable support for cross-border trade decision-making.
The trade data displayed on novartis institutes of biomedical is sourced from the 52wmb.com global trade database. It is based on legal records from customs and related public channels of various countries, and has been formatted and organized for user query and analysis.
We maintain compliance with the source and processing of data to ensure the objectivity of information, but due to the dynamic changes in international trade activities, some data may be delayed or changed.